| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.12.25 | RYMAN HEALTHCARE LIMITED: Ongoing Disclosure Notice for Dean Hamilton | 2 | ASX | ||
| 15.12.25 | RYMAN HEALTHCARE LIMITED: Ongoing Disclosure Notice - Dean Hamilton | 3 | NZX | ||
| 09.12.25 | RYMAN HEALTHCARE LIMITED: Ongoing Disclosure Notice - Naomi James | 2 | NZX | ||
| 09.12.25 | RYMAN HEALTHCARE LIMITED: Ongoing Disclosure Notice for Naomi James | - | ASX | ||
| 27.11.25 | Ryman Healthcare Slid To Loss In H1 | 394 | AFX News | WELLINGTON (dpa-AFX) - Ryman Healthcare Ltd. (RYM.NZ), a retirement village and rest home operator, on Thursday reported loss in the first half compared with the previous year. For the half... ► Artikel lesen | |
| 26.11.25 | RYMAN HEALTHCARE LIMITED: Ryman Healthcare reports 1H26 results | 12 | NZX | ||
| 23.11.25 | RYMAN HEALTHCARE LIMITED: Successful completion of full bank debt refinance | 3 | NZX | ||
| 06.11.25 | RYMAN HEALTHCARE LIMITED: Becoming a substantial holder | 39 | ASX | ||
| RYMAN HEALTHCARE LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 30.10.25 | RYMAN HEALTHCARE LIMITED: 1H26 half year results webcast details | 6 | NZX | ||
| 09.10.25 | Ryman Healthcare Sees Sales Rebound | 11 | Finance News Network | ||
| 08.10.25 | RYMAN HEALTHCARE LIMITED: Second quarter trading update | 14 | NZX | ||
| 01.10.25 | RYMAN HEALTHCARE LIMITED: Ryman Healthcare lists on the ASX | 15 | ASX | ||
| 29.09.25 | RYMAN HEALTHCARE LIMITED: ASX Pre-Quotation Disclosure | 2 | ASX | ||
| 29.09.25 | RYMAN HEALTHCARE LIMITED: Statement of Directors | 4 | ASX | ||
| 29.09.25 | RYMAN HEALTHCARE LIMITED: 2025 Annual Report to shareholders | 17 | ASX | ||
| 29.09.25 | RYMAN HEALTHCARE LIMITED: 2024 Annual Report to shareholders | - | ASX | ||
| 29.09.25 | RYMAN HEALTHCARE LIMITED: Constitution | - | ASX | ||
| 29.09.25 | RYMAN HEALTHCARE LIMITED: Information Form and Checklist Annexure 2 | - | ASX | ||
| 29.09.25 | RYMAN HEALTHCARE LIMITED: Information Form and Checklist | 1 | ASX | ||
| 29.09.25 | RYMAN HEALTHCARE LIMITED: Appendix 1C | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 45,320 | +0,94 % | SIEMENS HEALTHINEERS AG im strukturellen Gleichgewicht | ||
| INTELLIGENT BIO SOLUTIONS | 11,000 | 0,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins | NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,880 | -1,53 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,020 | 0,00 % | Piper Sandler raises Alignment Healthcare stock price target to $30 on strong sales | ||
| BRIGHTSPRING HEALTH SERVICES | 39,260 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,240 | +4,61 % | CARL ZEISS MEDITEC AG zündet - TecDAX-Gewinner mit Sogwirkung! | ||
| PROCEPT BIOROBOTICS | 33,130 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS | 48,270 | +1,22 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| BETA BIONICS | 29,570 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROGYNY | 26,645 | +3,52 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| CERIBELL | 20,810 | 0,00 % | Protara, CeriBell rise on FDA breakthrough designations | ||
| AVEANNA HEALTHCARE | 8,220 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| PACS GROUP | 39,720 | 0,00 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ADAPTHEALTH | 9,780 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| GENEDX | 131,41 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen |